1. (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007;J Allergy Clin Immunol,2007
2. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2021. Available at: www.ginasthma.org. Accessed May 5, 2022.
3. The surprising reintroduction of Primatene Mist in the United States;Sadreameli;Ann Am Thorac Soc.,2019
4. Amphastar Pharmaceuticals, Inc., U.S. Securities and Exchange Commission Form 10-K, Fiscal Year ending December 31, 2021. Available at: https://ir.amphastar.com/download/companies/270152a/Annual%20Reports/Annual%20Report%20(15).pdf. Accessed March 11, 2022.
5. Gottlieb S. FDA statement on approval of OTC Primatene Mist to treat mild asthma. US Food and Drug Administration. Available at: https://www.fda.gov/news-events/press-announcements/fda-statement-approval-otc-primatene-mist-treat-mild-asthma. Accessed January 29, 2022.